Florida Senate - 2012                        COMMITTEE AMENDMENT
       Bill No. SB 1198
                                Barcode 794354                          
                              LEGISLATIVE ACTION                        
                    Senate             .             House              
                  Comm: RCS            .                                
                  01/31/2012           .                                

       The Committee on Health Regulation (Diaz de la Portilla)
       recommended the following:
    1         Senate Amendment (with title amendment)
    3         Between lines 263 and 264
    4  insert:
    5         Section 4. Paragraph (b) of subsection (7) of section
    6  893.055, Florida Statutes, is amended to read:
    7         893.055 Prescription drug monitoring program.—
    8         (7)
    9         (b) A pharmacy, prescriber, or dispenser shall have access
   10  to information in the prescription drug monitoring program’s
   11  database which relates to a patient, or a potential patient, of
   12  that pharmacy, prescriber, or dispenser in a manner established
   13  by the department as needed for the purpose of reviewing the
   14  patient’s controlled substance prescription history. Other
   15  access to the program’s database shall be limited to the
   16  program’s manager and to the designated program and support
   17  staff, who may act only at the direction of the program manager
   18  or, in the absence of the program manager, as authorized. Access
   19  by the program manager or such designated staff is for
   20  prescription drug program management only or for management of
   21  the program’s database and its system in support of the
   22  requirements of this section and in furtherance of the
   23  prescription drug monitoring program. Confidential and exempt
   24  information in the database shall be released only as provided
   25  in paragraph (c) and s. 893.0551. The program manager,
   26  designated program and support staff who act at the direction of
   27  or in the absence of the program manager, and any individual who
   28  has similar access regarding the management of the database from
   29  the prescription drug monitoring program shall submit
   30  fingerprints to the department for background screening. The
   31  department shall follow the procedure established by the
   32  Department of Law Enforcement to request a statewide criminal
   33  history record check and to request that the Department of Law
   34  Enforcement forward the fingerprints to the Federal Bureau of
   35  Investigation for a national criminal history record check.
   37  ================= T I T L E  A M E N D M E N T ================
   38         And the title is amended as follows:
   39         Delete line 19
   40  and insert:
   41         board-certified psychiatrist or rheumatologist;
   42         amending s. 893.055, F.S.; requiring that a pharmacy,
   43         prescriber, or dispenser have access to information in
   44         the prescription drug monitoring program’s database
   45         which relates to a patient, or a potential patient, of
   46         that pharmacy, prescriber, or dispenser for the
   47         purpose of reviewing the patient’s controlled
   48         substance prescription history;